Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
FUJIFILM Irvine Scientific, a world leader in the development and manufacture of serum-free and chemically […]
FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell […]
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, […]
FUJIFILM Irvine Scientific Opens European Manufacturing Facility
FUJIFILM Irvine Scientific, Inc., today announced that its new manufacturing facility in Tilburg, the Netherlands is […]
FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility
FUJIFILM Irvine Scientific, Inc., today announced that it completed construction and started the commissioning phase of its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more